Aphasia and Other Acquired Neurogenic Language Disorders : A Guide for Clinical Excellence. This item is unavailable.Aphasia and Other Acquired Neurogenic Language Disorders : A Guide for Clinical Excellence

Covering an array of evidence-based content, including aphasia, traumatic brain injury, dementia, and language in aging, Aphasia and Other Acquired Neurogenic Language Disorders: A Guide for Clinical Excellence, Second Edition is a must-have textbook for clinicians and students studying to be speech-language pathologists. This clinical guide strategically addresses scientific foundations, service delivery, international and multicultural perspectives, assessment, and treatment.

 

Organized to maximize adult learning, the book is adaptable for multiple pedagogic methods for classroom-based courses, independent study, and online learning. The second edition of Aphasia and Other Acquired Neurogenic Language Disorders: A Guide for Clinical Excellence provides clinicians and students a clear pathway for quality and effectiveness in clinical practice.

New to the Second Edition

 

• Expanded content to reflect important recent developments throughout, with findings from over 500 new studies
• A thoroughly updated chapter on primary progressive aphasia and other neurodegenerative conditions
• Inclusion of additional voices of people with neurogenic conditions to highlight person-centered strengths and needs
• Updated attention to culturally responsive terminology and content throughout to promote diversity, equity, and inclusion
• Improved information flow based on reviewers’ feedback, while maintaining structure to ease transitions in course design for instructors who used the first edition
• Enhanced and updated foci on cognitive-communicative challenges associated with dementia, traumatic brain injury, and right brain injury
• Many new images and illustrations to support learning
• Abundant resources to encourage research collaboration and career development, and to promote supportive networks for people affected by neurogenic communication disorders
• Expanded foci on evidence-based practice, practice-based evidence, participatory research, and implementation science

Key Features

 

• A rigorous approach to the art and science of clinical practice, integrating diverse theoretical perspectives for a global readership
• Guidance on advocacy, ethics, reimbursement, legal aspects, and counseling
• An emphasis on person-centered, empowering approaches to maximize life participation
• Extensive assessment resources and a process analysis approach for analyzing communicative performance and interpreting assessment results
• How-to content on more than 50 intervention approaches
• Diagrams, charts, illustrations, summary tables, a substantial glossary, a detailed index, and rich up-to-date references
• Content design applying adult learning research to maximize deep learning
• Systematic queries that enliven clear objectives for knowledge, skills/application, and values
• A PluralPlus companion website with materials for students and instructors

Pedagogy Includes

 

• Extensive assessment resources and a process analysis approach for analyzing communicative performance and interpreting assessment results
• Clear clinical examples to ensure relevance of information based on realistic scenarios
• Systematic queries that enliven clear learning objectives
• Diagrams, charts, illustrations, summary tables, a substantial glossary, a detailed index, and rich up-to-date references
• Key terms in bold within the chapter and listed in a glossary

Brooke Hallowell, PhD, CCC-SLP, brings to this book over 30 years of clinical, research, teaching, and advocacy experience to support adults with acquired neurogenic communication challenges. She serves on boards and committees of several national and international organizations, including Aphasia Access, the National Aphasia Association, the Academy of Neurologic Communication Disorders and Sciences, and the American Speech-Language-Hearing Association (ASHA). She is a founding representative of the Global Rehabilitation Alliance (GRA), an affiliate of the World Health Organization (WHO) in Geneva, Switzerland, and serves on the GRA’s advocacy committee. She is an active consultant to the WHO on guidance regarding rehabilitation related to COVID-19, and she chairs ASHA’s committee on ethics in global engagement. She is also an editorial board member and reviewer for many scholarly journals and granting agencies.